Evero-1 (Evero 1)
Everolimus Tablet
Product Images NDC 67877-721
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 67877-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Evero-2 (Evero 2)
Evero-3 (Evero 3)
Evero-bottle-1mg-60s (Evero Bottle 1mg 60s)
Each tablet of Everolimus contains an unspecified amount of the drug. It is recommended to refer to the package insert for the proper dosage. The tablets should be stored at a temperature not exceeding 25°C (77°F) but may be kept between 15°C to 30°C (59°F to 86°F). The medication should be protected from light and moisture. In case of side effects, call a doctor or report to the FDA. Everolimus Tablets are manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Ascend Laboratories, LLC in Parsippany, New Jersey. The tablets are dispensed in a USP tight container, with 60 tablets per bottle. Additional labeling may contain a UV varnish, with barcode and a serial identification number. A medical license number (MBI0S/106) and PLS code (PLS0022T) are also listed. This medication is only available with a prescription.*
Evero-fig-1 (Evero Fig 1)
Evero-str (Evero Str)
Evero- (Evero)
This appears to be a description of a medication called Everolimus Tablets. The tablets are dispensed with a medication guide enclosed or provided separately. The tablets come in a container with 10 tablets each, and each tablet has 0.25 mg of the medication. The medication is only available with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
